Genzum Raises $20M For Generic Pharmaceuticals Effort

Los Angeles-based biopharmaceuticals firm Genzum has raised $20M in a funding round, according to backer SG LLC. According to SG, its Alternative Investments Division invested $20M in Genzum, to go towards that company's expansion of its pipeline of generic pharmaceutical products. Genzum develops, commercializes, and licenses generic pharmaceutical products, and is led by Chris Achar. More information »